JSSH
VERA icon

J. Safra Sarasin Holding’s Vera Therapeutics VERA Stock Holding History

J. Safra Sarasin Holding’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Buy
47,662
+34,629
+266% +$1.29M 0.03% 259
2026
Q1 		$524K Sell
13,033
-39,294
-75% -$1.69M 0.01% 404
2025
Q4 		$2.65M Sell
52,327
-2,990
-5% -$106K 0.04% 177
2025
Q3 		$1.61M Buy
55,317
+25,750
+87% +$595K 0.03% 234
2025
Q2 		$697K Buy
+29,567
New +$665K 0.01% 328

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

J. Safra Sarasin Holding's VERA Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its Vera Therapeutics (VERA) stake by 266% in Q2 2026, buying an estimated $1.29M and bringing the position to 47,662 shares worth $2.05M. The position accounts for 0.03% of the portfolio, ranked #259.

J. Safra Sarasin Holding first reported a position in VERA in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.65M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • J. Safra Sarasin Holding held 47,662 shares of Vera Therapeutics worth $2.05M as of Q2 2026.
  • J. Safra Sarasin Holding bought 34,629 Vera Therapeutics shares in Q2 2026, an estimated $1.29M.
  • Vera Therapeutics made up 0.03% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #259 holding.
  • J. Safra Sarasin Holding first reported a position in Vera Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • J. Safra Sarasin Holding's Vera Therapeutics position peaked at $2.65M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.